Precise patient stratification in esophageal cancer: Biomarkers for immunochemotherapy

Shogo Kumagai1, Shohei Koyama2, Kohei Shitara3

  • 1Division of Cancer Immunology, Research Institute/Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, Tokyo/Kashiwa, Japan; Division of Cellular Signaling, Research Institute, National Cancer Center, Tokyo, Japan.

Cancer Cell
|July 11, 2023
PubMed